BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30366876)

  • 1. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
    Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
    Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
    Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
    J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present status of prophylactic thyroidectomy in pediatric multiple endocrine neoplasia 2: a nationwide survey in Japan 1997-2017.
    Matsushita R; Nagasaki K; Ayabe T; Miyoshi Y; Kinjo S; Haruna H; Ihara K; Hasegawa T; Ida S; Ozono K; Minamitani K;
    J Pediatr Endocrinol Metab; 2019 Jun; 32(6):585-595. PubMed ID: 31150358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
    Lau GS; Lang BH; Lo CY; Tso A; Garcia-Barcelo MM; Tam PK; Lam KS
    Hong Kong Med J; 2009 Oct; 15(5):326-31. PubMed ID: 19801688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
    Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P
    J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic thyroidectomy for asymptomatic 3-year-old boy with positive multiple endocrine neoplasia type 2A mutation (codon 634).
    Jesić MD; Tancić-Gajić M; Jesić MM; Zivaljević V; Sajić S; Vujović S; Damjanović S
    Srp Arh Celok Lek; 2014; 142(1-2):72-4. PubMed ID: 24684035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].
    Ramos C; Ojeda D; Cohn D; Wohllk N
    Rev Med Chil; 2005 Sep; 133(9):1029-36. PubMed ID: 16311694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome.
    Lallier M; St-Vil D; Giroux M; Huot C; Gaboury L; Oligny L; Desjardins JG
    J Pediatr Surg; 1998 Jun; 33(6):846-8. PubMed ID: 9660211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.